IP Library Granted Patent US 12677847
Granted Patent B2
US 12677847 · App. 18/515,987 · Granted Jul 14, 2026

Methods and formulations for reducing bovine emissions

Inventors: Cory T. Herr (Greenfield, IN); John Charles Kube (Greenfield, IN); Jerold Scott Teeter (Greenfield, IN)
Assignee: Elanco US Inc.
A23K20/111A23K10/40A23K20/121A23K20/132A23K20/184A23K20/195A23K50/10A23K10/00A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12677847
App. No.
18/515,987
Granted
Jul 14, 2026
Kind
B2
Abstract

The present disclosure provides methods and formulations for reducing ammonia and carbon dioxide emissions from a bovine using lubabegron, or a physiologically acceptable salt thereof. The present disclosure also provides bovine feed additives and bovine feed compositions.

Claims (13)

1 . A method of increasing bovine hot carcass weight, comprising administering lubabegron, or a physiologically acceptable salt thereof, to the bovine.

2 . The method of claim 1 , wherein the physiologically acceptable salt of lubabegron is the hemifumarate salt of lubabegron.

3 . The method of claim 1 , wherein one or more other active ingredients selected from the group consisting of monensin, tylosin, and melengestrol, or physiologically acceptable salts thereof, are administered to the bovine.

4 . The method of claim 1 , wherein the bovine is a cow.

5 . The method of claim 1 , wherein the bovine is in confinement for slaughter when lubabegron, or a physiologically acceptable salt thereof is administered.

6 . The method according to claim 1 , wherein the lubabegron, or a physiologically acceptable salt thereof, is administered orally.

7 . The method according to claim 6 , wherein the lubabegron is administered in animal feed, in a feed additive, or in drinking water.

8 . The method according to claim 7 , wherein the feed is dry feed or a liquid.

9 . The method according to claim 6 , wherein the lubabegron is administered orally by bolus or gavage treatment.

10 . The method according to claim 1 , wherein the lubabegron is administered daily up to 91 days prior to slaughter of the bovine.

11 . The method according to claim 10 , wherein the lubabegron, or a physiologically acceptable salt thereof, is administrated to the bovine daily up to 14 to 56 days prior to slaughter of the bovine.

12 . The method according to claim 7 , wherein the animal feed comprises from about 1.25 to about 20 grams of lubabegron per ton, or a physiologically acceptable salt thereof.

13 . The method according to claim 12 , wherein the animal feed comprises from about 5 to 10 grams of lubabegron per ton.